Skip to main content

Table 1 Demographic data of patients with HF taking LQF

From: LuQi Formula relieves ventricular remodeling through improvement of HIF-1α-mediated intestinal barrier integrity

Variables

Patients ( n = 17)

Age ( year)

 

  ≤ 50

3 ( 17.6%)

  50–80

9 ( 52.9%)

   ≥ 80

5 ( 29.4%)

Gender

 

  Male

13 ( 76.4%)

  Female

4 ( 23.5%)

NYHA Grade

 

  Grade II

9 (52.9%)

  Grade III

5 (29.4%)

  Grade IV

3 (17.6%)